Editorial: Bispecific Antibodies for T-Cell Based Immunotherapy

Bibliographic Details
Main Authors: Brian H. Santich, Nai-Kong V. Cheung, Christian Klein
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-12-01
Series:Frontiers in Oncology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2020.628005/full
id doaj-9e10b8d3dd8449898eedd45e488cbdda
record_format Article
spelling doaj-9e10b8d3dd8449898eedd45e488cbdda2020-12-09T06:39:51ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2020-12-011010.3389/fonc.2020.628005628005Editorial: Bispecific Antibodies for T-Cell Based ImmunotherapyBrian H. Santich0Nai-Kong V. Cheung1Christian Klein2Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, NY, United StatesDepartment of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, NY, United StatesCancer Immunotherapy Discovery, Roche Innovation Center Zurich, Schlieren, Switzerlandhttps://www.frontiersin.org/articles/10.3389/fonc.2020.628005/fullbispecific antibodyT-cellimmunotherapyprotein engineeringoncology
collection DOAJ
language English
format Article
sources DOAJ
author Brian H. Santich
Nai-Kong V. Cheung
Christian Klein
spellingShingle Brian H. Santich
Nai-Kong V. Cheung
Christian Klein
Editorial: Bispecific Antibodies for T-Cell Based Immunotherapy
Frontiers in Oncology
bispecific antibody
T-cell
immunotherapy
protein engineering
oncology
author_facet Brian H. Santich
Nai-Kong V. Cheung
Christian Klein
author_sort Brian H. Santich
title Editorial: Bispecific Antibodies for T-Cell Based Immunotherapy
title_short Editorial: Bispecific Antibodies for T-Cell Based Immunotherapy
title_full Editorial: Bispecific Antibodies for T-Cell Based Immunotherapy
title_fullStr Editorial: Bispecific Antibodies for T-Cell Based Immunotherapy
title_full_unstemmed Editorial: Bispecific Antibodies for T-Cell Based Immunotherapy
title_sort editorial: bispecific antibodies for t-cell based immunotherapy
publisher Frontiers Media S.A.
series Frontiers in Oncology
issn 2234-943X
publishDate 2020-12-01
topic bispecific antibody
T-cell
immunotherapy
protein engineering
oncology
url https://www.frontiersin.org/articles/10.3389/fonc.2020.628005/full
work_keys_str_mv AT brianhsantich editorialbispecificantibodiesfortcellbasedimmunotherapy
AT naikongvcheung editorialbispecificantibodiesfortcellbasedimmunotherapy
AT christianklein editorialbispecificantibodiesfortcellbasedimmunotherapy
_version_ 1724388323138469888